跳至主要内容
临床试验/NCT02047279
NCT02047279已完成不适用

Left Atrium Reduction Versus no Left Atrium Reduction for Patients With Enlarged Left Atria and Persistent or Long Standing Persistent Atrial Fibrillation Undergoing Mitral Valve Surgery

Meshalkin Research Institute of Pathology of Circulation2 个研究点 分布在 2 个国家目标入组 120 人开始时间: 2014年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120
试验地点
2
主要终点
Freedom from atrial fibrillation

研究概览

简要总结

The purpose of this study is to estimate left atrial volume reduction surgery concomitant with the maze procedure and mitral valve repair/replacement in patients with atrial fibrillation with an enlarged left atria.

详细描述

The Cox-Maze procedure has been a gold standard for the treatment of atrial fibrillation. Success of the modified maze procedure after valvular operation with an enlarged left atria and persistent and longstanding persistent atrial fibrillation remains suboptimal. The question addressed was: In adults undergoing a maze procedure for atrial fibrillation does left atrial size reduction compared to maze surgery alone improve maze surgery success?

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Able to sign Informed Consent and Release of Medical Information forms
  • Age ≥ 18 years
  • Clinical indications for mitral valve surgery for organic mitral valve disease Note: May include need for surgical management of functional tricuspid regurgitation or patent foramen ovale. Surgical intervention may be performed via sternotomy or minimally invasive procedure.
  • a) Persistent atrial fibrillation (AF) within 6 months prior to randomization, defined as non self-terminating AF lasting greater than 7 days but no more than one year, or lasting less than 7 days but necessitating pharmacologic or electrical cardioversion.
  • Duration of AF must be documented by medical history and Presence of AF must be documented by a direct electrocardiographic assessment within 6 months prior to randomization.
  • b) Longstanding persistent AF is defined as continuous AF of greater than one year duration.
  • Duration of AF must be documented by medical history and Presence of AF must be documented by a direct electrocardiographic assessment upon arrival in the OR.
  • left atrial diameter > 65mm
  • Able to use heart rhythm monitor

排除标准

  • AF is paroxysmal
  • AF without indication for mitral valve surgery
  • Concomitant coronary artery bypass grafting (CABG), aortic arch or aortic valve procedure
  • Previous catheter ablation for AF
  • Redo cardiac surgery
  • Left ventricle ejection fraction (LV EF) < 35%
  • Life expectancy of less than one year
  • Mental impairment or other conditions that may not allow subject to understand the nature, significance, and scope of study

结局指标

主要结局

Freedom from atrial fibrillation

时间窗: 12 months

次要结局

  • Rate of significant adverse events(12 months)

研究者

发起方
Meshalkin Research Institute of Pathology of Circulation
申办方类型
Network
责任方
Principal Investigator
主要研究者

Alexander Bogachev-Prokophiev

PhD

Meshalkin Research Institute of Pathology of Circulation

研究点 (2)

Loading locations...

相似试验